Sutent - Newsfeeds

Pipeline Review: Bristol-Myers Squibb's 5 Keys to Success: It's the same strategy that Pfizer followed for Sutent and that Bayer and Onyx Pharmaceuticals followed for Nexavar. All three drugs inhibit growth factor receptors required for blood vessel growth. No blood,
Chemo for Cancer Patients With HIV May Change: Treatments that Work While they specifically tested a new chemotherapy called Sutent, the study applies to about half of all cancer drugs that use the same enzymes. ?Patients treated with one type of drug cocktail to ...
Sector Wrap: Technology, Pharmaceuticals: Pfizer (NYSE:PFE) said that its phase 3 trial of Sutent to treat non-small cell lung cancer failed to meet its primary endpoint. Sutent did not show increased overall survival when used in combination with Tarceva ...
Pfizer Failure Clears Way for Small Biotech ArQule: The Big Pharma announced Monday night that its cancer drug Sutent didn't show statistically significant improvement of overall survival in second- and third-line non-small cell lung cancer patients -- the primary ...
Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With ...: ... the trade name Afinitor® (everolimus) tablets for the treatment of patients with advanced renal cell carcinoma (RCC) after failure of treatment with sunitinib or sorafenib. Pancreatic NET can grow aggressively and ...
Bevacizumab Linked to Increased Risk for High-Grade Proteinuria and Nephrotic Syndrome: ... class effect of vascular endothelial growth factor (VEGF) inhibitors and that "other VEGF-signaling blockers including axitinib, VEGF Trap, sorafenib, and sunitinib have also been associated with severe proteinuria ...
Cancer patients 'can't wait a year for drugs cash': The 37-year-old had fought against a decision by health chiefs at NHS West Kent not to fund Sunitinib. They claimed there was not enough evidence to prove the drug, which is used for kidney cancer, would work on her ...
Consortium Seeks Best Treatment for HIV-positive Cancer Patients: Washington, DC – Preliminary findings from a unique study with sunitinib suggest that it might be possible to tweak the dosage of chemotherapy drugs used to treat HIV-positive cancer patients to achieve therapeutic ...
Argos Therapeutics Presents Positive Phase 2 Data for Arcelis(TM) Dendritic Cell-based...: ... positive interim data from a Phase 2 trial that evaluated the clinical activity, safety and immune response of AGS-003 treatment, given in combination with sunitinib, in patients with newly diagnosed advanced renal ...
Chemotherapy drug sunitinib promising for HIV-positive cancer patients: For reasons that are unclear, cancers that are unrelated to HIV infection are growing at an alarming rate in these patients, compared to the general HIV-negative population, he says. These non-AIDS-defining cancers are ...

Argos Therapeutics Presents Positive Phase 2 Data for Arcelis Dendritic Cell-based Immunotherapy in ...: ... positive interim data from a Phase 2 trial that evaluated the clinical activity, safety and immune response of AGS-003 treatment, given in combination with sunitinib, in patients with newly diagnosed advanced renal ...
Kidney Damage Affirmed with Biologic-Chemo Combo: ... s group noted, saying it may be a class effect given elevated severe proteinuria rates seen in trials with axitinib, sorafenib (Nexavar), and sunitinib (Sutent). The authors noted several limitations including the ...
Cancer Meeting's Winners And Losers: Pfizer had a success this meeting with a lung cancer drug for patients with a rare genetic mutation, but big studies of its Sutent in breast cancer failed. The hottest new area this year was in drugs that boost the ...
Seeking The Best Treatment For HIV-Positive Cancer Patients: This study is testing the safety of the chemotherapy drug sunitinib ( Sutent ) and has enrolled patients into two groups of HIV patients - group 1: those using non-nuceleotide analog reverse transcription inhibitors ...
How Pfizer's Pain Could Be Your Gain: In March, The New York-based pharma giant announced that two late-stage breast cancer trials of its drug Sutent didn't meet the primary endpoints. On top of the Sutent flop, the company also announced that it’s ...
Pfizer Drug Targets Gene Flaw to Shrink Lung Tumors (Update1): That same month, the company said Sutent, approved for kidney and stomach cancers, failed in two studies to shrink tumors of the breast, and its experimental drug figitumumab didn’t help lung cancer patients.
What Happened at ASCO Over the Weekend: And Pfizer’s Sutent, already shown to work in kidney cancer, does not produce similar beneficial effects in breast cancer patients. There was some good news in the breast cancer field, however, with Eisai’s ...
People on HIV Meds Might Need Different Chemo Doses for Cancer: A study in progress suggests that the dose of Sutent (sunitinib)—a chemotherapy—might need to be adjusted up or down depending on the antiretroviral (ARV) treatment a person is taking. The authors of the study, to be ...
HORMONE REFRACTORY PROSTATE CANCER: NEW STUDIES IN ...: The third trial at the Medical University of Vienna will test the combination of docetaxel with the tyrosine kinase inhibitor sunitinib. As part of the trial, the researchers will examine biomarkers in the patients' blood that will yield information ...
Life-saving cancer drugs still not available on NHS: They include Hycamtin (topotecan), for lung and cervical cancer, Mabthera (rituximab) for chronic lymphocytic leukaemia and Sutent (sunitinib) for stomach tumours. Sir Andrew Dillon, chief executive of Nice, insisted however that partial ...

Want to contact a Washington, DC Sutent lawyer? ...Get a free case evaluation from one of our Washington, DC Sutent lawyers now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Pages: 1 2 Next

Need A Sutent Attorney?

First Name Last Name Email Address State

Legal Issue

DrugWatch: Sutent Click to select a Legal Issue

Has Your Health Been Negatively Affected?

Please Describe the Injury

close this window

Sutent Information

Click to View Our Legal Resources

Want to contact a Washington, DC Sutent lawyer? ...Get a free case evaluation from one of our Washington, DC Sutent lawyers now.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120223-005515

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

DrugWatch: Sutent Click to select a Legal Issue

Close (x)

Find Legal Help for Your Sutent Case - Submit Your Information Below

Do you need legal assistance with your Sutent case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * DrugWatch: Sutent Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.